Prevacid TV Ad Revisions Increase Prominence Of Indication After FDA Letter
Executive Summary
TAP has revised its TV ad for Prevacid by increasing the prominence of the drug's indication in response to a letter from FDA's ad division
You may also be interested in...
DTC Is Not Improving, Rep. Waxman Says: Viagra Ads Show “Six” Sells?
The decline in advertising enforcement actions by FDA does not reflect better compliance in direct-to-consumer advertisements, House Government Reform Committee Ranking Member Henry Waxman (D-Calif.) maintains
DTC Is Not Improving, Rep. Waxman Says: Viagra Ads Show “Six” Sells?
The decline in advertising enforcement actions by FDA does not reflect better compliance in direct-to-consumer advertisements, House Government Reform Committee Ranking Member Henry Waxman (D-Calif.) maintains
TAP Prevacid
TAP is revising its 60-second "Heartbreak Hotel" ad in response to FDA objections. A March 15 letter from the ad division maintains that the ad did not sufficiently present the limitations to the indication for Prevacid or the side effect information. TAP has resolved the issue with the agency and a corrected version of the ad will run shortly, the Takeda/Abbott joint venture said